Stocks Health care AKAN

NASDAQ · Health care

Akanda Corp. (AKAN)

Akanda Corp. reported revenue of $836.7K in fiscal 2024, up 97.5% from a year earlier. It posted a net loss of $4.1M. In fiscal 2024 capital spending exceeded operating cash flow by $6.1M. At December 31, 2024 it held $3.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on June 9, 2026.

Watch AKAN in 60 seconds

Follow AKAN

Free, no password. An email when AKAN files with the SEC.

Key facts about Akanda Corp.

Net worth

Akanda Corp. has a market value (market cap) of $397.1K at the latest share price, and shareholders' equity of $4.3M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2024 revenue was $836.7K (+97.5% year on year), with a net loss of $4.1M.

Cash flow

In fiscal 2024 operations used $4M of cash.

Latest report

The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on June 9, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Akanda Corp. does

Akanda Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker AKAN.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where AKAN ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Akanda Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. October 1, 2026
   IPO registration (foreign issuer) F-1
2. September 30, 2026
   Foreign issuer update 6-K
3. September 25, 2026
   Foreign issuer update 6-K
4. September 9, 2026
   Foreign issuer update 6-K
5. September 4, 2026
   Foreign issuer update 6-K
6. August 17, 2026
   Foreign issuer update 6-K
7. August 13, 2026
   Foreign issuer update 6-K
8. June 18, 2026
   Foreign issuer update 6-K
9. June 12, 2026
   Foreign issuer update 6-K
10. June 9, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025

Recent insider filings (Forms 3, 4 and 144): 4, the latest on January 20, 2026. Insider transactions on SEC

Insider trades

What the people running Akanda Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns AKAN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 7,816 shares in total, about $5.7K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about AKAN

What does Akanda Corp. do?

Akanda Corp. is a company in the Health care sector, listed on NASDAQ as AKAN. Its shares trade on NASDAQ under the ticker AKAN.

What is Akanda Corp.'s net worth?

Akanda Corp. has a market value (market cap) of $397.1K at the latest share price, and shareholders' equity of $4.3M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Akanda Corp. profitable?

No. In fiscal 2024 it reported a net loss of $4.1M on revenue of $836.7K.

How much revenue does Akanda Corp. make?

In fiscal 2024 Akanda Corp. reported revenue of $836.7K. That is 97.5% more than a year earlier.

When did Akanda Corp. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 9, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the iPO registration (foreign issuer) from October 1, 2026.

Similar companies

Compare AKAN with

Compare AKAN with any company

Follow AKAN

Get an email when Akanda Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow AKAN

Free, no password. An email when AKAN files with the SEC.

Where the numbers come from

Financial figures are the values Akanda Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.